AJANTPHARMNSEAjanta Pharma Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 20 Jan, 2026 · 10:23 IST

Ajanta Pharma denies Burger King stake acquisition rumours

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹2678.90
prior close
₹2685.90
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-2.5%+3.1% vs market
Pharmaceuticals peers, median of 157sector-2.1%+2.7% vs sector

On the reaction day the stock moved 3.1 pts more than Nifty Midcap 150 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.0
15m
-0.1
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6-2.5+3.1-2.1+2.7
Next day
+1.3-3.5+4.8-3.4+4.7
2d
+1.3-2.3+3.6-2.0+3.3
3d
+0.8-4.0+4.8-3.4+4.1
4d
+0.9-3.5+4.3-3.5+4.4
5d
+1.2-1.9+3.1-3.2+4.4
1w
+3.3-1.8+5.1-2.2+5.6
15d
+8.1+2.2+5.8+1.0+7.1
1m
+9.6+0.2+9.4-1.8+11.3
2m
+12.7-7.5+20.3-8.0+20.7
3m
+3.6+0.7+2.9-0.4+4.0
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajanta Pharma has officially denied media reports linking it to a potential stake acquisition in Restaurant Brands Asia, the operator of Burger King in India. Reuters and other publications had mentioned Ajanta in connection with a stake purchase by Everstone. Ajanta clarified that neither the company nor its management is party to or involved in the transaction, and has not entered into, discussed, negotiated, or considered any such proposal. The company called the reference in the news article incorrect and denied circulating speculation on social media.

Likely market impact

Removes speculative acquisition upside. Stock may remain volatile from social media chatter despite official denial of rumours.